Cargando…
Synthetically Lethal Nanoparticles for Treatment of Endometrial Cancer
Uterine serous carcinoma, one of the most aggressive types of endometrial cancer, is characterized by poor outcomes and mutations in the tumor suppressor p53. Our objective was to engender synthetic lethality to paclitaxel, the frontline treatment for endometrial cancer, in tumors with mutant p53 an...
Autores principales: | Ebeid, Kareem, Meng, Xiangbing, Thiel, Kristina W, Do, Anh-Vu, Geary, Sean M, Morris, Angie S, Pham, Erica L, Wongrakpanich, Amaraporn, Chhonker, Yashpal S, Murry, Daryl J, Leslie, Kimberly K, Salem, Aliasger K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762267/ https://www.ncbi.nlm.nih.gov/pubmed/29203914 http://dx.doi.org/10.1038/s41565-017-0009-7 |
Ejemplares similares
-
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
por: Meng, Xiangbing, et al.
Publicado: (2013) -
LC–MS/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study
por: Chhonker, Yashpal S., et al.
Publicado: (2018) -
The Absence of CpG in Plasmid DNA–Chitosan
Polyplexes Enhances Transfection Efficiencies and Reduces Inflammatory
Responses in Murine Lungs
por: Wongrakpanich, Amaraporn, et al.
Publicado: (2014) -
Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
por: He, Qingfeng, et al.
Publicado: (2020) -
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
por: Smith, Rasheid, et al.
Publicado: (2022)